Last week, Fidson Healthcare Plc, a leading name in the pharmaceutical sector, showcased its dedication and growth by announcing a robust dividend of 55 kobo per share for the fiscal year ending on December 31, 2022. This significant announcement was made during its 24th Annual General Meeting held in Lagos. This payout signals a 10 percent growth from the 50 kobo per share distributed in the 2021 financial year.
Aligning with its ambition to continually serve the burgeoning demand for essential therapeutic drugs in Nigeria and broader West African regions, Fidson is gearing up to enhance its pharmaceutical production capacity.
In its financial report, the company revealed an impressive turnover of N40.634 billion for 2022, marking a 31.7 percent rise from the N30.861 billion reported in 2021.
Dr. Fidelis Ayebae, Founder and Managing Director of Fidson Healthcare Plc, voiced his gratitude to the company’s stakeholders and loyal customer base. “Our trajectory of success has always been intertwined with the unwavering trust and consistent patronage our customers have shown us. This dedication fuels our commitment to excellence, ensuring not just considerable returns but also consolidating our leadership position in the market,” Dr. Ayebae stated.
He emphasized the company’s determination to persevere even amidst challenging business environments, by enhancing internal controls, nurturing upcoming leaders, and cementing a corporate culture focused on profitability and societal value addition.
Shedding light on the company’s future vision, he remarked, “Considering Fidson’s dynamic expansion strategy, our keenness for forging meaningful partnerships, and our emphasis on employee growth, we’re confident about steering the company towards prolonged success and industry dominance.”
The Annual General Meeting also saw the presentation of Dr. Vincent Ahonkhai, Mrs. Aishatu P. Sadauki, and Mr. Emmanuel E. Imoagene for re-election as non-executive directors. They received unanimous approval from the shareholders.
Mr. Segun Adebanji (FCA), Chairman of the Board, underscored the invaluable expertise these board members bring, ensuring top-tier discussions and aiding in achieving the firm’s strategic goals.
Shareholders voiced their contentment with the firm’s achievements. Chief Timothy Adesiyan lauded Fidson’s consistent dividend payments. “Even when competitors are facing downturns or pondering delisting, Fidson never ceases to deliver outstanding value,” he remarked. Similarly, Barrister Adetutu Siyonbola praised the company for its transparency and punctuality in hosting its annual general meetings.
SOURCE: VANGUARDÂ
